Ticker

Predictive Oncology (NASDAQ: POAI - Get Free Report) and Mitesco (OTCMKTS:MITI - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, institutional ownership and dividends. Analyst Ratings This is a breakdown of current

Healthcare Triangle (NASDAQ: HCTI - Get Free Report) and Predictive Oncology (NASDAQ: POAI - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends. Analyst Recommendations This is a summary of

Predictive Oncology Inc. (NASDAQ: POAI - Get Free Report) shares passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $10.47 and traded as low as $6.52. Predictive Oncology shares last traded at $6.7596, with a volume of 40,332 shares changing hands. Analyst Upgrades and Downgrades A

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Axe Compute Inc. (NASDAQ: AGPU) (the “Company” or “Axe Compute”) today announced that it has changed its name to Axe Compute Inc., with its common stock to begin trading on Nasdaq under the ticker symbol AGPU on December 12, 2025. Axe Compute will continue to operate its AI-driven drug discovery business and plans to expand its business into high-performance enterprise AI…